NOV 10, 2020 8:45 AM PST

Liposomal Delivery Could Help Prevent Doxorubicin Cardiotoxicity

WRITTEN BY: Jasper Cantrell

One of the greatest failures of modern cancer therapies is the rather substantial off-target toxic effects many radio-, chemo-, and immunotherapies have. We have made great strides to improve these treatments but never-the-less struggle to get toxicity-free therapy to patients.

Cancer therapies range in methodology, mechanism of action, and effectiveness. Some therapies favor certain types of cancers, while others seem to affect a variety of cancers. Unfortunately, nearly all of these therapies essentially involve poisons that are designed to target cancer cells. As cancer cells are nearly identical to healthy cells in most ways, this often leads to off-target toxicities. These toxicities need to be accounted for before a patient engages in any specific treatment.

Breast cancer is one of the most common cancers in the world, with many well-studied treatments. One such treatment is doxorubicin, which unfortunately has some issues with cardiotoxicity. However, a newer version of doxorubicin using liposomal delivery (a type of delivery system using lipids) has shown to be less cardiotoxic than doxorubicin alone.

In a new study, a team from the Centre of Postgraduate Medical Education in Poland investigated how liposomal doxorubicin affected patient factors like overall survival and the amount of cardiotoxicity experienced. They did this by taking data from eight oncology centers in Poland and analyzing liposomal doxorubicin therapy results against other cancer therapies.

The team gathered data from 402 metastatic breast cancer patients, of which only 126 managed to complete their liposomal doxorubicin treatments. Analyzing these patients’ heart health and comparing them to patients treated with doxorubicin alone or other similar chemotherapies showed that liposomal doxorubicin was linked to a healthier heart after treatment. Overall survival comparison showed that only when liposomal doxorubicin was a secondary therapy or other specific incidences was there a significant difference.

With toxicity being a consistent issue with many cancer therapies, there is a keen interest in producing a therapy with little to no toxic side-effects. Liposomal doxorubicin is one such option, and this study found that it had lower cardiotoxicity than doxorubicin alone. This finding supports the use of liposomal doxorubicin in patients at a high risk of cardiovascular disease.

The team concludes that there needs to be more study, as several other factors increase cardiovascular disease incidence, such as diabetes.  The study concludes, “in patients with metastatic BC, prolonged liposomal doxorubicin treatment, i.e. lasting more than 3.5 months, and thus the administration of a higher cumulative dose, i.e. above 300 mg/m2, significantly increases OS.”

Sources: Nature Scientific Reports, British Heart Foundation

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
FEB 02, 2021
Cardiology
Investigating a Stress Protein's Relation to Heart Failure
FEB 02, 2021
Investigating a Stress Protein's Relation to Heart Failure
As medicine advances, the world’s population gradually becomes older and older. Cardiovascular disease becomes mor ...
APR 01, 2021
Health & Medicine
Flavanol-rich Foods Protect Heart from Stress
APR 01, 2021
Flavanol-rich Foods Protect Heart from Stress
Drinking hot cocoa is comforting on cold winter nights, and new research from the University of Birmingham shows that it ...
JUN 07, 2021
Cardiology
Researchers Find a Way to Improve Outcomes After a Heart Attack
JUN 07, 2021
Researchers Find a Way to Improve Outcomes After a Heart Attack
It's thought that in the United States, there is a heart attack once every 40 seconds, or that each year, about 80,0 ...
JUN 28, 2021
Cardiology
The Electricity of a Beating Heart is Caught on Graphene Camera
JUN 28, 2021
The Electricity of a Beating Heart is Caught on Graphene Camera
When graphene was first developed, it was hailed as a revolutionary material but its potential uses seemed unclear to ma ...
JUN 29, 2021
Cancer
Heart Failure Linked to Increased Cancer Risk
JUN 29, 2021
Heart Failure Linked to Increased Cancer Risk
A study by researchers in Germany suggests that patients with heart failure are more likely to develop cancer than those ...
SEP 05, 2021
Cardiology
Eating Walnuts & Pecans Can Help Lower 'Bad' Cholesterol
SEP 05, 2021
Eating Walnuts & Pecans Can Help Lower 'Bad' Cholesterol
Some nuts, especially walnuts, have high levels of healthy fats like Omega-3. New research reported in Circulation has s ...
Loading Comments...